| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2357 |
Injection, omalizumab, 5 mg |
1,682 |
509 |
$634K |
| J2182 |
Injection, mepolizumab, 1 mg |
224 |
157 |
$351K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
13,942 |
3,815 |
$298K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,531 |
4,137 |
$139K |
| 96401 |
|
3,070 |
1,629 |
$108K |
| 99223 |
Prolong inpt eval add15 m |
1,010 |
872 |
$58K |
| 99222 |
Initial hospital care, per day, moderate complexity |
1,023 |
846 |
$45K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
395 |
265 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
808 |
589 |
$15K |
| 99233 |
Prolong inpt eval add15 m |
217 |
100 |
$7K |
| 99458 |
|
398 |
230 |
$3K |
| 99457 |
|
548 |
345 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
546 |
351 |
$3K |
| 99454 |
|
409 |
238 |
$2K |
| 99442 |
|
217 |
144 |
$2K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
152 |
80 |
$2K |
| 94729 |
|
85 |
80 |
$329.07 |
| 94060 |
|
41 |
38 |
$277.18 |
| 90682 |
|
27 |
23 |
$256.40 |
| 94727 |
|
19 |
15 |
$241.77 |
| 99453 |
|
44 |
30 |
$236.26 |
| 94375 |
|
30 |
29 |
$186.91 |
| 90694 |
|
22 |
12 |
$130.74 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
18 |
12 |
$103.24 |
| G0008 |
Administration of influenza virus vaccine |
18 |
16 |
$0.32 |
| 99439 |
|
303 |
186 |
$0.00 |
| 99490 |
Ccm add 20min |
318 |
199 |
$0.00 |